相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases
Mohamed Attauabi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study
Ahmad Albshesh et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn's disease
N. Dussias et al.
JOURNAL OF CROHNS & COLITIS (2021)
Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification
Rahul S. Dalal et al.
INFLAMMATORY BOWEL DISEASES (2021)
ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
Michael Dolinger et al.
INFLAMMATORY BOWEL DISEASES (2020)
The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor
Hadrien Alric et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Effectiveness and safety of vedolizumab in biologically naive patients: A real-world multi-centre study
Fabio Salvatore Macaluso et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience
Uri Kopylov et al.
DIGESTIVE AND LIVER DISEASE (2019)
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study
Claire Liefferinckx et al.
JOURNAL OF CROHNS & COLITIS (2019)
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry
M. Iborra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence
Tal Engel et al.
DIGESTIVE AND LIVER DISEASE (2019)
Second-Line Biologic Therapy After Vedolizumab
Timothy E. Ritter et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn's Disease: Real-World Data from a German IBD Cohort
Alica Kubesch et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils
Siddharth Singh
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2019)
Vedolizumab in IBD-Lessons From Real-world Experience; A Systematic Review and Pooled Analysis
Tal Engel et al.
JOURNAL OF CROHNS & COLITIS (2018)
Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease
S. Singh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study
Uri Kopylov et al.
INFLAMMATORY BOWEL DISEASES (2018)
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
Eugenia Shmidt et al.
INFLAMMATORY BOWEL DISEASES (2018)
Anti-TNF Therapy in Crohn's Disease
Samuel O. Adegbola et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors' reply
Erwin Dreesen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response
E. Dreesen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
Bruce E. Sands et al.
INFLAMMATORY BOWEL DISEASES (2017)
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Carl Eriksson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab
Jessica R. Allegretti et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
D. C. Baumgart et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
Aurelien Amiot et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease
Uri Kopylov et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
Glen S. Hazlewood et al.
GASTROENTEROLOGY (2015)
Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease
R. W. Stidham et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
Vincent Billioud et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
分享论文
